Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ENPP2 | Q13822 | 2/20 | 0.64 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.59 |
| ▸ | P2RY10 | O00398 | 4/20 | 0.59 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.59 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16714278 | 1.00 | ENPP2 (0.64) | ENPP2RECQLBLMTDP1LPAR3 | |
| SCHEMBL2126025 | 0.95 | PRKCE (0.61) | ENPP2RECQLBLMTDP1LPAR3 | |
| SCHEMBL3645476 | 0.94 | ENPP2 (0.57) | ENPP2RECQLBLMTDP1LPAR3 | |
| SCHEMBL15526366 | 0.93 | ENPP2 (0.59) | ENPP2LPAR3LPAR1 | |
| SCHEMBL1402383 | 0.93 | ENPP2 (0.59) | ENPP2LPAR3LPAR1 | |
| SCHEMBL8017848 | 0.89 | ENPP2 (0.60) | ENPP2RECQLBLMTDP1LPAR3 | |
| SCHEMBL23209666 | 0.88 | SELP (0.71) | ENPP2LPAR3P2RY10GPR34LPAR1 | |
| SCHEMBL23387627 | 0.88 | SELP (0.71) | ENPP2LPAR3P2RY10GPR34LPAR1 | |
| SCHEMBL21641453 | 0.88 | SELP (0.71) | ENPP2LPAR3P2RY10GPR34LPAR1 | |
| SCHEMBL23256430 | 0.88 | SELP (0.71) | ENPP2LPAR3P2RY10GPR34LPAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9610334-B2 | Truncated secretory aspartyl proteinase 2 | ISTITUTO SUPERIORE DI SANITA (IT) | 2017-04-04 | — | — | US | disclosed |
| EP-2467155-B1 | MULTIEPITOPE VACCINE FOR HER2/NEU-ASSOCIATED CANCERS | BIOLIFE SCIENCE QLD LTD (AU) | 2015-11-11 | — | — | EP | disclosed |
| US-8852604-B2 | Multiepitope vaccine for Her2/neu-associated cancers | PEVION BIOTECH AG (CH) | 2014-10-07 | — | — | US | disclosed |
| US-20140193445-A1 | Truncated Secretory Aspartyl Proteinase 2 | ISTITUTO SUPERIORE DI SANITA (IT) | 2014-07-10 | — | — | US | disclosed |
| US-8715698-B2 | Truncated secretory aspartyl proteinase 2 | PEVION BIOTECH, AG (CH) | 2014-05-06 | — | — | US | disclosed |
| US-8496962-B2 | Trans-adjuvant system | PEVION BIOTECH, LTD. (CH) | 2013-07-30 | — | — | US | disclosed |
| US-8367077-B2 | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof | PEVION BIOTECH, AG (CH) | 2013-02-05 | — | — | US | disclosed |
| EP-2201109-B1 | TRUNCATED SECRETORY ASPARTYL PROTEINASE 2 | PEVION BIOTECH LTD (CH) | 2012-10-03 | — | — | EP | disclosed |
| CN-101815505-B | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof | PEVION BIOTECH AG | 2012-09-19 | — | — | CN | disclosed |
| US-20120195962-A1 | Multiepitope Vaccine for Her2/Neu-Associated Cancers | PEVION BIOTECH AG (CH) | 2012-08-02 | — | — | US | disclosed |
| CN-101815505-A | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof | PEVION BIOTECH AG | 2010-08-25 | — | — | CN | disclosed |
| EP-2201109-A1 | TRUNCATED SECRETORY ASPARTYL PROTEINASE 2 | Pevion Biotech Ltd. (CH) | 2010-06-30 | — | — | EP | disclosed |
| US-20100015214-A1 | Novel Trans-Adjuvant System | PEVION BIOTECH LTD. (CH) | 2010-01-21 | — | — | US | disclosed |
| EP-2117590-A1 | NON-SPECIFIC IMMUNOSTIMULATING AGENTS | Pevion Biotech AG (CH) | 2009-11-18 | — | — | EP | disclosed |
| WO-2009036997-A1 | TRUNCATED SECRETORY ASPARTYL PROTEINASE 2 | PEVION BIOTECH LTD. (CH) | 2009-03-26 | — | — | WO | disclosed |
| EP-2039764-A1 | Truncated secretory aspartyl proteinase 2 | Pevion Biotech AG (CH) | 2009-03-25 | — | — | EP | disclosed |
| EP-2014279-A1 | Virosomes comprising hemagglutinin derived from an influenza virus produced in a cell line, compositions, methods of manufacturing, use thereof | Pevion Biotech AG (CH) | 2009-01-14 | — | — | EP | disclosed |
| WO-2008080628-A1 | NON-SPECIFIC IMMUNOSTIMULATING AGENTS | PEVION BIOTECH AG (CH) | 2008-07-10 | — | — | WO | disclosed |
| EP-1938835-A1 | Non-specific immunostimulating agents | Pevion Biotech AG (CH) | 2008-07-02 | — | — | EP | disclosed |
| EP-1797895-A1 | An adjuvant system comprising virosomes and liposomes | Pevion Biotech Ltd. (CH) | 2007-06-20 | — | — | EP | disclosed |